BSEM logo

BIOSTEM TECHNOLOGIES INC

BSEMNASDAQ
🏆 #4514 by market capEarnings Nov 17US Equity
——
Quote unavailable
🔔
Track BSEM
Get earnings, price moves & breaking news on Telegram
Track
24h—
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$28M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
93.5%
High
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
—
Insufficient data
No chart data available for BSEM.

Trading Snapshot

Day Range
—
52-Week Range
$1.40 – $8.40
Volume (shares)
—
Avg Volume (shares)
—
Shares Outstanding
18.7M
Next Earnings
2026-11-17

Fundamentals Snapshot

Annual Revenue
$47M
Last Q Revenue
$8M
P/E Ratio
—
P/S Ratio
—
EPS (TTM)
$-1.20
Dividend Yield
—
Dilution (1yr)
−26.7%
BSEM logo

BIOSTEM TECHNOLOGIES INC

BSEM
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$47M▼ −84.3% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
93.1%▼ −2.4% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$689K▼ −102.2% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$7M▼ −72.6% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
16.7M▼ −26.7% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$26M▲ +$8M YoY
StockOtter · stockotter.space

About BIOSTEM TECHNOLOGIES INC

BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human connective tissue matrix for homologous use; and American Amnion, a human connective tissue matrix for homologous use. The company was formerly known as Caribbean International Holdings Inc. and changed its name to BioStem Technologies, Inc. in August 2014. BioStem Technologies, Inc. was incorporated in 2006 and is based in Fort Lauderdale, Florida.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

💎Quality★★★★★
💧Dilution★★★★★
Overall Score
Insufficient data
—/100
Analyst data unavailable.

Latest News & Updates

News unavailable.